Search

Search Constraints

You searched for: Author/Creator Dombi, Eva

Search Results

1. 18‐fluorodeoxyglucose‐positron emission tomography (FDG‐PET) evaluation of nodular lesions in patients with neurofibromatosis type 1 and plexiform neurofibromas (PN) or malignant peripheral nerve sheath tumors (MPNST)1. Issue 1 (29th May 2012)

2. Are Some Randomized Clinical Trials Impossible?. Issue 1 (January 2021)

3. Association of plexiform neurofibroma volume changes and development of clinical morbidities in neurofibromatosis 1. Issue 12 (28th April 2018)

4. Cediranib phase‐II study in children with metastatic alveolar soft‐part sarcoma (ASPS). Issue 12 (10th September 2019)

5. CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies. Issue 3 (17th January 2014)

6. Current whole-body MRI applications in the neurofibromatoses: NF1, NF2, and schwannomatosis. (16th August 2016)

9. Feasibility of magnetic resonance-guided high-intensity focused ultrasound treatment targeting distinct nodular lesions in neurofibromatosis type 1. Issue 1 (18th August 2021)

10. Imaging Evaluation of Plexiform Neurofibromas in Neurofibromatosis Type 1: A Survey-Based Assessment. Issue 7 (17th August 2021)